These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24365456)

  • 21. Loneliness in psychotic illness and its association with cardiometabolic disorders.
    Badcock JC; Mackinnon A; Waterreus A; Watts GF; Castle D; McGrath JJ; Morgan VA
    Schizophr Res; 2019 Feb; 204():90-95. PubMed ID: 30243852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and correlates of problem gambling in people with psychotic disorders.
    Haydock M; Cowlishaw S; Harvey C; Castle D
    Compr Psychiatry; 2015 Apr; 58():122-9. PubMed ID: 25684263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disability and service use among homeless people living with psychotic disorders.
    Herrman H; Evert H; Harvey C; Gureje O; Pinzone T; Gordon I
    Aust N Z J Psychiatry; 2004; 38(11-12):965-74. PubMed ID: 15555033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and correlates of suboptimal vitamin D status in people living with psychotic disorders: Data from the Australian Survey of High Impact Psychosis.
    Suetani S; Saha S; Eyles DW; Scott JG; McGrath JJ
    Aust N Z J Psychiatry; 2017 Sep; 51(9):921-929. PubMed ID: 28829181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Environment With the Risk of Developing Psychotic Disorders in Rural Populations: Findings from the Social Epidemiology of Psychoses in East Anglia Study.
    Richardson L; Hameed Y; Perez J; Jones PB; Kirkbride JB
    JAMA Psychiatry; 2018 Jan; 75(1):75-83. PubMed ID: 29188295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Care-giving by people with psychotic disorders in the second Australian prevalence study of psychosis.
    Poon AWC; Hayes L; Harvey C
    Health Soc Care Community; 2019 Jul; 27(4):1042-1052. PubMed ID: 30723953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance use in a population-based clinic sample of people with first-episode psychosis.
    Barnett JH; Werners U; Secher SM; Hill KE; Brazil R; Masson K; Pernet DE; Kirkbride JB; Murray GK; Bullmore ET; Jones PB
    Br J Psychiatry; 2007 Jun; 190():515-20. PubMed ID: 17541112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mental health recovery and physical health outcomes in psychotic illness: Longitudinal data from the Western Australian survey of high impact psychosis catchments.
    Morgan VA; Waterreus A; Ambrosi T; Badcock JC; Cox K; Watts GF; Shymko G; Velayudhan A; Dragovic M; Jablensky A
    Aust N Z J Psychiatry; 2021 Jul; 55(7):711-728. PubMed ID: 32921130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation.
    Sara GE; Large MM; Matheson SL; Burgess PM; Malhi GS; Whiteford HA; Hall WD
    Aust N Z J Psychiatry; 2015 Feb; 49(2):106-17. PubMed ID: 25518844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study.
    Carr VJ; Neil AL; Halpin SA; Holmes S; Lewin TJ
    Aust N Z J Psychiatry; 2003 Feb; 37(1):31-40. PubMed ID: 12534654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia.
    Hahn L; Rigby A; Galletly C
    Aust N Z J Psychiatry; 2014 Jan; 48(1):70-9. PubMed ID: 23739313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling the incidence and mortality of psychotic disorders: data from the second Australian national survey of psychosis.
    Saha S; Whiteford H; McGrath J
    Aust N Z J Psychiatry; 2014 Apr; 48(4):352-9. PubMed ID: 24270308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.
    Suvisaari JM; Saarni SI; Perälä J; Suvisaari JV; Härkänen T; Lönnqvist J; Reunanen A
    J Clin Psychiatry; 2007 Jul; 68(7):1045-55. PubMed ID: 17685741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of drug use on the age at onset of psychotic disorders in an Australian cohort.
    Stefanis NC; Dragovic M; Power BD; Jablensky A; Castle D; Morgan VA
    Schizophr Res; 2014 Jul; 156(2-3):211-6. PubMed ID: 24831390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotic patients with unclear diagnoses. A descriptive analysis.
    Fennig S; Bromet EJ; Craig T; Jandorf L; Schwartz JE
    J Nerv Ment Dis; 1995 Apr; 183(4):207-13. PubMed ID: 7714509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial.
    Gardner-Sood P; Lally J; Smith S; Atakan Z; Ismail K; Greenwood KE; Keen A; O'Brien C; Onagbesan O; Fung C; Papanastasiou E; Eberhard J; Patel A; Ohlsen R; Stahl D; David A; Hopkins D; Murray RM; Gaughran F;
    Psychol Med; 2015; 45(12):2619-29. PubMed ID: 25961431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults.
    Varghese D; Scott J; Welham J; Bor W; Najman J; O'Callaghan M; Williams G; McGrath J
    Schizophr Bull; 2011 Mar; 37(2):389-93. PubMed ID: 19687152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.